Lifecore Biomedical, Inc. (NasdaqGS: LFCR)
Health Care · Life Sciences Tools & Services · US
$6.45
-0.08% today · -2.7% 1Y
Lifecore Biomedical, Inc. (NasdaqGS: LFCR) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $244.15M and employs 382 people.
Over the last twelve months the share price has lost 2.7%, trading between 3.63 and 8.98.
Tweenvest scores Lifecore Biomedical, Inc. across four factors: quality 40/100, value 51/100, growth 5/100. Its strongest factor is value.
LFCR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $244.15M
- Revenue (TTM)
- $129.46M
- P/E
- —
- EPS
- -0.93
- Dividend yield
- —
- Beta (5Y)
- 0.98
- 52-week high
- $8.98
- 52-week low
- $3.63
- Avg volume (3M)
- —
- Shares outstanding
- 37.85M
- Employees
- 382
- Next earnings
- —
About Lifecore Biomedical, Inc.
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
- ISIN
- US5147661046
- Founded
- 1965
- Listed since
- Feb 15, 1996
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Nautilus Biotechnology, Inc.NasdaqCM: NAUT | $286.32M | $1.90 | -15.78% |
| Standard BioTools Inc.NasdaqGS: LAB | $270.64M | $0.66 | -4.99% |
| Penetrium Bioscience Inc.KOSDAQ: A187660 | $257.45M | ₩6,320.00 | -9.97% |
| Vimta Labs LimitedBSE: 524394 | $248.09M | Rs537.15 | -7.97% |
| Dishman Carbogen Amcis LimitedNSEI: DCAL | $242.48M | Rs149.68 | -0.45% |
| Diaceutics PLCAIM: DXRX | $228.03M | £2.03 | -0.25% |
| Windlas Biotech LimitedNSEI: WINDLAS | $202.39M | Rs949.20 | -12.31% |
| Tarsons Products LimitedNSEI: TARSONS | $176.45M | Rs320.95 | -2.57% |
Figures last refreshed Oct 11, 2026.